Company Summary
Search
Home Page
 
Theralase Technologies Inc. 
Listed Company 
Current   Past  
Fiscal Year EndCompany StatusExempt Flag
December 31TradingN
Incorporation Locations
Inc. DateExpiry DateCountryRegionDescription
22/Aug/1989  Canada   
Exchange Filing Office
Location
Toronto Regional Service Office
Business Type(s)
Primary/SecondaryBusiness TypeDetails
Primary  Medical Device Development  And Marketing 
Securities
SymbolSecurity NameMarketStatus
TLTTheralase Technologies Inc.TSX VentureTRADING
TLT.WTTheralase Technologies Inc. wt 22Aug2024TSX VentureTRADING
Name HistoryFromTo
Theralase Technologies Inc.2/Nov/2004Present
Company Facts Reconciliation
SubjectDate Returned
Spring 2015 CFR Not Received
Associations
Auditing Firm:  Collins Barrow Toronto LLP
Auditor:  Collins Barrow
Investor Relations:  The Equicom Group Inc.
Law Firm:  Minden Gross LLP Toronto
Subsidiary:  Theralase Biotech Inc.
  Theralase Inc.
Transfer Agent:  TSX Trust Company
Latest Information
TypeDateTitle
News Releases  9/Oct/2018  NEWS RELEASE - ANTI CANCER TECHNOLOGY SHOWS PROMISE FOR ESOPHAG[MARKET NEWS]
    NEWS RELEASE - COMPLETION OF NON BROKERED PRIVATE PLACEMENT OF[MARKET NEWS]
    NEWS RELEASE - DISCOVERS CANNABINOID INCREASES EFFICACY OF PATE[MARKET NEWS]
Bulletins  22/Aug/2019  New Listing-Warrants
Meetings and Public Filings  Information on financial statements, public filings and corporate meetings for all Canadian public companies can be found at www.sedar.com
Property Locations
(not available)

* Historical Data